IP Library Granted Patent US 7,402,634
Granted Patent B2
US 7,402,634 · App. 11/173,707 · Granted Jul 22, 2008

Perfluorocyclobutane copolymers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,402,634
App. No.
11/173,707
Granted
Jul 22, 2008
Kind
B2
Abstract

The present invention provides copolymer having repeating units based on polyoxyalkylene radicals, polysiloxane radicals and perfluorocyclobutane radicals. The copolymers are useful as biomedical devices such as contact lenses or intraocular lenses.

Claims (23)

1. A perfluorocyclobutane ring-containing copolymer which is obtained by copolymerization of at least two of the following prepolymers (a) T -(P) n -T, (b) T 1 -(P 1 ) n -T 1 and (c) T 2 -(P 2 ) n -T 2 wherein n is independently 1 to about 100,000 and T, T 1 and T 2 are independently of the general formula

wherein L is an optional linking group and is independently a straight or branched C 1 -C 30 alkyl group, a C 3 -C 30 cycloalkyl group, a C 5 -C 30 aryl group, an ether group, a C 1 -C 20 ester group, an amide group, a siloxanyl, an arylsiloxanyl or a fluorosiloxanyl, R 1 independently represents one or more inertly substituted groups; and each X is independently a group which links the inertly substituted groups and the trifluorovinyl group and is selected from the group consisting of a bond, an oxygen atom, a sulfur atom, a carboxylic ester group, a thiocarboxylic ester group, an amide group, a sulfone, a sulfoxide, a carbonate, a carbamate, a perfluoroalkylene, a perfluoroalkylene ether, an alkylene, an acetylene, a phosphine, a carbonyl group, a thiocarbonyl group, seleno, telluro, nitrido, a silanediyl group, a trisilanediyl group, a tetrasilanetetrayl group, a siloxanediyl group, a disiloxanediyl group, a trisiloxyldiyl group, a trisilazanyl group, a silythio group, a boranediyl group and combinations thereof; P is independently an oxyalkylene radical of the general formula

wherein R 2 and R 3 are independently hydrogen, a straight or branched C 1 -C 6 alkyl group, a C 3 -C 30 cycloalkyl group, a C 5 -C 30 aryl group, a straight or branched C 1 -C 6 fluoroalkyl group, a C 3 -C 30 fluorocycloalkyl group, a C 5 -C 30 fluoroaryl group, an ether group, a C 1 -C 20 ester group, an amide group, an amine group, fluorine, a vinyl group, or a hydroxyl group and m is 1 to about 10; P 1 is a polysiloxane radical of the general formula

wherein R 4 and R 5 are independently hydrogen, a straight or branched C 1 -C 6 alkyl group, a C 3 -C 30 cycloalkyl group, a C 5 -C 30 aryl group, a straight or branched C 1 -C 6 fluoroalkyl group, a C 3 -C 30 fluorocycloalkyl group, a C 5 -C 30 fluoroaryl group, an ether group, a C 1 -C 20 ester group, C 1 -C 6 alkoxy group, an amide group an amine group, fluorine, a vinyl group, or a hydroxyl group; and P 2 is a perfluorocyclobutane radical of the general formula

wherein R 6 independently represents one or more inertly substituted groups and X′ is independently a bond, an oxygen atom, a sulfur atom, a carboxylic or thiocarboxylic ester group, a sulfone, a sulfoxide, perfluoroalkylene, perfluoroalkylene ether, alkylene, acetylene, a phosphine, a carbonyl or thiocarbonyl group; seleno; telluro; nitrido; a silanediyl group, a trisilanedjyl group, a tetrasilanetetrayl group, a siloxanediyl group, a disiloxanediyl group, a trisiloxyl group, a trisilazanyl group, a silythio group, or a boranediyl group.

2. The perfluorocyclobutane ring-containing copolymer of claim 1 , wherein R 1 and R 6 are independently selected from the group consisting of

wherein R is independently hydrogen, a C 1 -C 20 alkyl group, a hydroxyl group, a C 1 -C 20 carboxylic acid group, a C 1 -C 20 ester group, a C 1 -C 20 alkoxy group, CO 2 − , SO 3 − , PO 3 − OPO 3 2− , F, Br, I, NA 2 or NA 3 30 wherein A is independently hydrogen, a C 1 -C 20 alkyl group, a hydroxyl group, a C 1 -C 20 carboxylic acid group, a C 1 -C 20 ester group, or a C 1 -C 20 alkoxy group, or two R groups together with the carbon atom to which they are bonded are joined together to form a cyclic structure optionally containing one or more heterocyclic groups; R 7 is a bond, a C 1 -C 20 alkylene or haloalkylene group optionally containing ether or ester linkages and wherein the X group and either the L or P or P 1 or P 2 group may independently be bonded to the aromatic group either ortho, meta and/or para with respect one another.

3. The perfluorocyclobutane ring-containing copolymer of claim 1 , wherein the prepolymer T-(P) n -T has a number average molecular weight of from about 100 about 100,000.

4. The perfluorocyclobutane ring-containing copolymer of claim 1 , wherein the prepolymer T 1 -(P 1 ) n -T 1 has a number average molecular weight of from about 100 about 100,000.

5. The perfluorocyclobutane ring-containing copolymer of claim 1 , wherein the prepolymer T 2 -(P 2 ) n -T 2 has a number average molecular weight of from about 100 about 100,000.

6. The perfluorocyclobutane ring-containing copolymer of claim 1 , which is obtained by copolymerizing one or more of the prepolymer T-(P) n T with one or more of the prepolymer T 1 -(P 1 ) n -T 1 .

7. The perfluorocyclobutane ring-containing copolymer of claim 1 , which is obtained by copolymerizing one or more of the prepolymer T 1 -(P 1 ) n -T 1 with one or more of the prepolymer T 2 -(P 2 ) n -T 2 .

8. The perfluorocyclobutane ring-containing copolymer of claim 1 , which is obtained by copolymerizing one or more of the prepolymer T 1 -(P 1 ) n -T 1 with one or more of the prepolymer T 2 -(P 2 ) n -T 2 .

9. The perfluorocyclobutane ring-containing copolymer of claim 1 , which is obtained by copolymerizing one or more of the prepolymer T-(P) n -T with one or more of the prepolymer T 1 -(P 1 ) n -T 1 and with one or more of the prepolymer T 2 -(P 2 ) n -T 2 .

10. A process for preparing a copolymer comprising polymerizing at least two of the following prepolymers (a) T-(P) n -T, (b) T 1 -(P 1 ) n -T 1 and (c) T 2 -(P 2 ) n -T 2 for a sufficient time to form the perfluoro containing copolymer, wherein n is independently 1 to about 100,000 and T, T 1 and T 2 are independently of the general formula

wherein L is an optional linking group and is independently a straight or branched C 1 -C 30 alkyl group, a C 3 -C 30 cycloalkyl group, a C 5 -C 30 aryl group, an ether group, a C 1 -C 20 ester group, an amide group, a siloxanyl, an arylsiloxanyl or a fluorosiloxanyl, R 1 independently represents one or more inertly substituted groups; and each X is independently a group which links the inertly substituted groups and the trifluorovinyl group and is selected from the group consisting of a bond, an oxygen atom, a sulfur atom, a carboxylic ester group, a thiocarboxylic ester group, an amide group, a sulfone, a sulfoxide, a carbonate, a carbamate, a perfluoroalkvlene, a perfluoroalkylene ether, an alkylene, an acetylene, a phosphine, a carbonyl group, a thiocarbonyl group, seleno, telluro, nitrido, a silanediyl group, a trisilanedivl group, a tetrasilanetetrayl group, a siloxanediyl group, a disiloxanedjyl group, a trisiloxyldiyl group, a trisilazanyl group, a silythio group, a boranediyl group and combinations thereof; P is independently an oxyalkylene radical of the general formula

wherein R 2 and R 3 are independently hydrogen, a straight or branched C 1 -C 6 alkyl group, a C 3 -C 30 cycloalkyl group, a C 5 -C 30 aryl group, a straight or branched C 1 -C 6 fluoroalkyl group, a C 3 -C 30 fluorocycloalkyl group, a C 5 -C 30 fluoroaryl group, an ether group, a C 1 -C 20 ester group, an amide group, an amine group, fluorine, a vinyl group, or a hydroxyl group and m is 1 to about 10; P 1 is a polysiloxane radical of the general formula

wherein R 4 and R 5 are independently hydrogen, a straight or branched C 1 -C 6 alkyl group, a C 3 -C 30 cycloalkyl group, a C 5 -C 30 aryl group, a straight or branched C 1 -C 6 fluoroalkyl group, a C 3 -C 30 fluorocycloalkyl group, a C 5 -C 30 fluoroaryl group, an ether group, a C 1 -C 20 ester group, C 1 -C 6 alkoxy group, an amide group an amine group, fluorine, a vinyl group, or a hydroxyl group; and P 2 is a perfluorocyclobutane radical of the general formula

wherein X′ is independently a bond, an oxygen atom, a sulfur atom, a carboxylic or thiocarboxylic ester group, a sulfone, a sulfoxide, perfluoroalkylene, perfluoroalkylene ether, alkylene, acetylene, a phosphine, a carbonyl or thiocarbonyl group; seleno; telluro; nitrido; a silanedjyl group, a trisilanediyl group, a tetrasilanetetrayl group, a siloxanediyl group, a disiloxanediyl group, a trisiloxyl group, a trisilazanyl group, a silythio group, or a boranediyl group and R 6 independently represents one or more inertly substituted groups and wherein the perfluorocyclobutane prepolymer (c) T 2 -P 2 -T 2 can be generated in situ from one or more monomers having two dimerizable perfluorovinyl groups.

11. A biomedical device comprising the perfluorocyclobutane ring-containing copolymer of claim 1 .

12. The biomedical device of claim 11 , which is an ophthalmic lens.

13. The biomedical device of claim 12 , wherein the ophthalmic lens is a contact lens.

14. The biomedical device of claim 13 , wherein the contact lens is a rigid gas permeable lens.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Aug 1, 2008
From: WP PRISIM INC.; BAUSCH AND LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; IOLAB CORPORATION; RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; EYEONICS, INC.
To: CREDIT SUISSE
Reel/Frame 021328/0367 →
SECURITY AGREEMENT Recorded Nov 16, 2007
From: BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; IOLAB CORPORATION; RHC HOLDINGS, INC.; WP PRISM, INC.
To: CREDIT SUISSE
Reel/Frame 020122/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2005
From: SCHORZMAN, DEREK; SALAMONE, JOSEPH C.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 016728/0133 →